Arrowhead Pharmaceuticals Inc Analyst R&D Day Transcript
Everybody, thanks so much for joining us today. We are here for Arrowhead's Analyst Day in 2019.
And here is our forward-looking statement slide, it just says we will be making forward-looking statements today and please refer to all the disclosures and risk factors in our filings.
So today, what are we going to cover and who is going to talk to you? It's always nice to do these kind of events because we do a lot of broker conferences and scientific and medical meetings and we do our conference calls, but they're kind of quick hits. So we're only able to talk about certain targeted things and we're never really able to take a step back and talk about where were we, how far have we come and where are we going in the future and what's our strategy and what makes our R&D organization tick, and so that's what we're going to try to hit today.
So from the company, myself, and most of you know me, I'm Vince Anzalone, the Head of Investor Relations; Chris Anzalone, our President and CEO; Bruce Given, our COO
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
